Do you or someone you know suffer from cervical dystonia (also known as torticollis)? If so, read this article. Revance pharmaceutical reports positive results from the Aspen-1 Phase 3 clinical drug trial testing injections of DaxibotulinumtoxinA for patients with cervical dystonia.
Dr. Gitt was a principal investigator in this very important clinical drug trial. We are hopeful that the FDA will approve this treatment at some point soon. If you have cervical dystonia, and need assistance, Dr. Gitt is very experienced at the treatment of this disorder. Please call us if you have any questions, or with to schedule an appointment. 602-482-2116.
https://www.businesswire.com/news/home/20201014005360/en/